1. Home
  2. DOMO vs CTMX Comparison

DOMO vs CTMX Comparison

Compare DOMO & CTMX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DOMO
  • CTMX
  • Stock Information
  • Founded
  • DOMO 2010
  • CTMX 2008
  • Country
  • DOMO United States
  • CTMX United States
  • Employees
  • DOMO N/A
  • CTMX N/A
  • Industry
  • DOMO Computer Software: Prepackaged Software
  • CTMX Biotechnology: Pharmaceutical Preparations
  • Sector
  • DOMO Technology
  • CTMX Health Care
  • Exchange
  • DOMO Nasdaq
  • CTMX Nasdaq
  • Market Cap
  • DOMO 707.1M
  • CTMX 596.2M
  • IPO Year
  • DOMO 2018
  • CTMX 2015
  • Fundamental
  • Price
  • DOMO $13.08
  • CTMX $4.16
  • Analyst Decision
  • DOMO Buy
  • CTMX Strong Buy
  • Analyst Count
  • DOMO 8
  • CTMX 5
  • Target Price
  • DOMO $15.13
  • CTMX $5.80
  • AVG Volume (30 Days)
  • DOMO 547.2K
  • CTMX 3.7M
  • Earning Date
  • DOMO 12-04-2025
  • CTMX 11-06-2025
  • Dividend Yield
  • DOMO N/A
  • CTMX N/A
  • EPS Growth
  • DOMO N/A
  • CTMX 50.22
  • EPS
  • DOMO N/A
  • CTMX 0.24
  • Revenue
  • DOMO $318,363,000.00
  • CTMX $113,631,000.00
  • Revenue This Year
  • DOMO $2.32
  • CTMX N/A
  • Revenue Next Year
  • DOMO $2.72
  • CTMX N/A
  • P/E Ratio
  • DOMO N/A
  • CTMX $17.49
  • Revenue Growth
  • DOMO N/A
  • CTMX N/A
  • 52 Week Low
  • DOMO $6.01
  • CTMX $0.40
  • 52 Week High
  • DOMO $18.49
  • CTMX $4.62
  • Technical
  • Relative Strength Index (RSI)
  • DOMO 45.37
  • CTMX 62.76
  • Support Level
  • DOMO $12.09
  • CTMX $3.35
  • Resistance Level
  • DOMO $14.06
  • CTMX $4.62
  • Average True Range (ATR)
  • DOMO 0.57
  • CTMX 0.32
  • MACD
  • DOMO 0.04
  • CTMX 0.03
  • Stochastic Oscillator
  • DOMO 53.66
  • CTMX 65.60

About DOMO Domo Inc. Class B

Domo Inc provides a cloud-based platform that digitally connects all the data, systems, and people in an organization, giving them access to real-time data and insights and allowing them to manage their business from their smartphones. The company offers a platform to its customers as a subscription-based service. Users receive notifications on any device and immediately act on the invitation, after which the system can write back to the original system of record. The company derives revenue from subscriptions to its cloud-based platform and professional services.

About CTMX CytomX Therapeutics Inc.

CytomX Therapeutics Inc a clinical-stage, oncology-focused biopharmaceutical company developing novel, masked, conditionally activated biologics designed to be localized to the tumor microenvironment. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.

Share on Social Networks: